A carregar...
Engineering Next-Generation CAR-T Cells for Better Toxicity Management
Immunoadoptive therapy with genetically modified T lymphocytes expressing chimeric antigen receptors (CARs) has revolutionized the treatment of patients with hematologic cancers. Although clinical outcomes in B-cell malignancies are impressive, researchers are seeking to enhance the activity, persis...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7696189/ https://ncbi.nlm.nih.gov/pubmed/33207607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21228620 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|